142 related articles for article (PubMed ID: 8287597)
1. Bone marrow transplantation therapy using resistant donors for retrovirus-induced leukaemia in mice.
Iwai H; Day NK; Hamada N; Inaba MM; Ikehara S; Good RA
Clin Exp Immunol; 1994 Jan; 95(1):135-40. PubMed ID: 8287597
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow transplantation from Fv-4-resistant donors rescues Friend leukemia virus-infected mice from leukemia: a model of bone marrow transplantation therapy against retroviral infection.
Kitagawa M; Kamisaku H; Aizawa S; Sado T
Leukemia; 1994 Dec; 8(12):2200-6. PubMed ID: 7808008
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-12 administration in retroviral infection of mice increases the potential to produce functional dendritic cells from bone marrow stem cells.
Kelleher P; Williams NJ; Knight SC
Immunol Lett; 1999 Jan; 65(1-2):51-4. PubMed ID: 10065627
[TBL] [Abstract][Full Text] [Related]
4. Retrovirus-induced immunosuppression via blocking of dendritic cell migration and down-regulation of adhesion molecules.
Gabrilovich DI; Woods GM; Patterson S; Harvey JJ; Knight SC
Immunology; 1994 May; 82(1):82-7. PubMed ID: 8045596
[TBL] [Abstract][Full Text] [Related]
5. Graft-vs-leukemia and moderation of graft-vs-host reaction in transplantation therapy of viral leukemia.
Okunewick JP; Meredith RF; Raikow RB; Brozovich BJ; Magliere K
Exp Hematol; 1981 Aug; 9(7):754-65. PubMed ID: 7032959
[TBL] [Abstract][Full Text] [Related]
6. Murine models for antiretroviral therapy.
Ruprecht RM
Intervirology; 1989; 30 Suppl 1():2-11. PubMed ID: 2540110
[TBL] [Abstract][Full Text] [Related]
7. A gene therapy model for retrovirus-induced disease with a viral env gene: expression-dependent resistance in immunosuppressed hosts.
Kitagawa M; Aizawa S; Sado T; Yamaguchi S; Suzuki T; Hirokawa K; Ikeda H
Leukemia; 2001 Nov; 15(11):1779-84. PubMed ID: 11681421
[TBL] [Abstract][Full Text] [Related]
8. Effects of murine leukemia viruses on the function of dendritic cells.
Gabrilovich DI; Roberts MS; Harvey JJ; Botcherby M; Bedford PA; Knight SC
Eur J Immunol; 1993 Nov; 23(11):2932-8. PubMed ID: 8223870
[TBL] [Abstract][Full Text] [Related]
9. Histocompatibility influence in allogeneic marrow transplantation therapy of murine viral leukemia. I.--Studies of the relative influence of major versus minor histocompatibility determinants.
Meredith RF; Okunewick JP; Raikow RB; Brozovich BJ; Seeman PR; Magliere KC
Biomedicine; 1981 Feb; 34(1):11-7. PubMed ID: 7013840
[TBL] [Abstract][Full Text] [Related]
10. Role of lymphoid cells in age-related change of susceptibility to Friend leukemia virus-induced leukemia.
Yamaguchi S; Kitagawa M; Inoue M; Tejima Y; Kimura M; Aizawa S; Utsuyama M; Hirokawa K
Mech Ageing Dev; 2001 Feb; 122(2):219-32. PubMed ID: 11166360
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of CD3 and CD5 donor T cell depletion on graft-versus-leukemia in a murine model for MHC-matched unrelated-donor transplantation.
Okunewick JP; Kociban DL; Machen LL; Buffo MJ
Bone Marrow Transplant; 1994 Jan; 13(1):11-7. PubMed ID: 7517254
[TBL] [Abstract][Full Text] [Related]
12. Rauscher viral leukemogenesis in BALB/c mice treated with rabbit antimouse thymocyte serum.
Siegel BV; Morton JI
J Natl Cancer Inst; 1970 Mar; 44(3):573-9. PubMed ID: 11515425
[No Abstract] [Full Text] [Related]
13. Reconstitution of the W/Wv stem cell differentiation defect by infection with Rauscher leukemia virus.
Merchav S; Wagemaker G; van Bekkum DW
J Natl Cancer Inst; 1985 Aug; 75(2):361-8. PubMed ID: 3894753
[TBL] [Abstract][Full Text] [Related]
14. Mechanism for dendritic cell dysfunction in retroviral infection of mice.
Gabrilovich DI; Patterson S; Timofeev AV; Harvey JJ; Knight SC
Clin Immunol Immunopathol; 1996 Aug; 80(2):139-46. PubMed ID: 8764558
[TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide/X-ray: combined mode preparation for transplantation therapy.
Meredith R; OKunewick J; Shadduck R; Raikow R; Brozovich B; Seeman P
Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1467-70. PubMed ID: 395138
[No Abstract] [Full Text] [Related]
16. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
Nazarov V; Hilbert D; Wolff L
Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
[TBL] [Abstract][Full Text] [Related]
17. Effect of non-H-2-linked genes on anti-virus immune responses and long-term survival in mice persistently infected with E-55+ murine leukemia virus.
Avidan N; Tumas-Brundage KM; Sieck TG; Prystowsky MB; Blank KJ
Virology; 1995 Aug; 211(2):507-15. PubMed ID: 7645254
[TBL] [Abstract][Full Text] [Related]
18. Growth of transplantable melanoma and leukaemia and prevention of virus-induced leukaemia in long lived radiation chimeras constructed with unmanipulated bone marrow.
Pierpaoli W
Clin Exp Immunol; 1985 Jan; 59(1):210-6. PubMed ID: 3882284
[TBL] [Abstract][Full Text] [Related]
19. Defects in the function of dendritic cells in murine retroviral infection.
Gabrilovich DI; Patterson S; Harvey JJ; Woods GM; Elsley W; Knight SC
Adv Exp Med Biol; 1995; 378():469-72. PubMed ID: 8526120
[No Abstract] [Full Text] [Related]
20. Dendritic cells, apoptosis and murine retrovirus.
Woods GM; Gabrilovich DI; Elsley W; English N; Knight SC
Adv Exp Med Biol; 1995; 378():493-6. PubMed ID: 8526126
[No Abstract] [Full Text] [Related]
[Next] [New Search]
